Picture of Vireo Growth logo

VREO Vireo Growth Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSuper Stock

Annual cashflow statement for Vireo Growth, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

R2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-57.5-22.9-33.7-42.5-25.5
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items35.52.4213.12718.9
Unusual Items
Other Non-Cash Items
Changes in Working Capital-4.67.2-10-3.782.83
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Net Change in Other Assets & Liabilities
Cash from Operating Activities-26.9-10.9-30.5-18.1-0.966
Capital Expenditures-7.69-8.45-18-5.56-6.05
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-13.521.410.8-0.0552.58
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities-21.212.9-7.21-5.62-3.48
Financing Cash Flow Items0-0.120
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities47.715.925.823.75.26
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.3917.9-12-0.0060.815